- CLDX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Celldex Therapeutics (CLDX) S-3Shelf registration
Filed: 9 Oct 03, 12:00am
Exhibit 23.3
Consent of L.E.K. Consulting LLC
We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 of the summarization of our report to Avant Immunotherapeutics, Inc. (the "Company"), dated June 7, 2002, that is contained on page 6 in the last sentence of Section C.2. of Item 1 of the Annual Report on Form 10-K for the fiscal year ended December 31, 2002 filed by the Company.
/s/ L.E.K. Consulting LLC | /s/ Michael Clabault C.O.O. for L.E.K. Consulting LLC | |
Boston, Massachusetts October 8, 2003 |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.